Know more

About cookies

What is a "cookie"?

A "cookie" is a piece of information, usually small and identified by a name, which may be sent to your browser by a website you are visiting. Your web browser will store it for a period of time, and send it back to the web server each time you log on again.

Different types of cookies are placed on the sites:

  • Cookies strictly necessary for the proper functioning of the site
  • Cookies deposited by third party sites to improve the interactivity of the site, to collect statistics

Learn more about cookies and how they work

The different types of cookies used on this site

Cookies strictly necessary for the site to function

These cookies allow the main services of the site to function optimally. You can technically block them using your browser settings but your experience on the site may be degraded.

Furthermore, you have the possibility of opposing the use of audience measurement tracers strictly necessary for the functioning and current administration of the website in the cookie management window accessible via the link located in the footer of the site.

Technical cookies

Name of the cookie


Shelf life

CAS and PHP session cookies

Login credentials, session security



Saving your cookie consent choices

12 months

Audience measurement cookies (AT Internet)

Name of the cookie


Shelf life


Trace the visitor's route in order to establish visit statistics.

13 months


Store the anonymous ID of the visitor who starts the first time he visits the site

13 months


Identify the numbers (unique identifiers of a site) seen by the visitor and store the visitor's identifiers.

13 months

About the AT Internet audience measurement tool :

AT Internet's audience measurement tool Analytics is deployed on this site in order to obtain information on visitors' navigation and to improve its use.

The French data protection authority (CNIL) has granted an exemption to AT Internet's Web Analytics cookie. This tool is thus exempt from the collection of the Internet user's consent with regard to the deposit of analytics cookies. However, you can refuse the deposit of these cookies via the cookie management panel.

Good to know:

  • The data collected are not cross-checked with other processing operations
  • The deposited cookie is only used to produce anonymous statistics
  • The cookie does not allow the user's navigation on other sites to be tracked.

Third party cookies to improve the interactivity of the site

This site relies on certain services provided by third parties which allow :

  • to offer interactive content;
  • improve usability and facilitate the sharing of content on social networks;
  • view videos and animated presentations directly on our website;
  • protect form entries from robots;
  • monitor the performance of the site.

These third parties will collect and use your browsing data for their own purposes.

How to accept or reject cookies

When you start browsing an eZpublish site, the appearance of the "cookies" banner allows you to accept or refuse all the cookies we use. This banner will be displayed as long as you have not made a choice, even if you are browsing on another page of the site.

You can change your choices at any time by clicking on the "Cookie Management" link.

You can manage these cookies in your browser. Here are the procedures to follow: Firefox; Chrome; Explorer; Safari; Opera

For more information about the cookies we use, you can contact INRAE's Data Protection Officer by email at or by post at :


24, chemin de Borde Rouge -Auzeville - CS52627 31326 Castanet Tolosan cedex - France

Last update: May 2021

Menu Logo Principal Oniris

Home page

BabH: monitoring human Babesiosis in France and characterization of the responsible agents

Human Babesiosis: a One Health approach, working in collaboration with the medical community

Babesiosis is a tick-borne disease caused by the development of parasites of the genus Babesia in red blood cells1. Frequent and of moderate severity in the USA, symptomatic babesiosis is rare in Europe, but fatal in immuno-compromised individuals2. Humans are an "accidental" host and zoonotic species have domestic animals (cattle) or wild animals (micro-mammals, deer) as natural hosts3,4. As a research laboratory working on these species and their epidemiology for more than 20 years, we maintain a watch on humans in order to refine diagnostic methods and knowledge on these zoonotic agents5, but also to detect the emergence or establishment of newly introduced species.
Our work shows a high seroprevalence in humans, indicating frequent exposure to the parasite, but the actual presence of Babesia (molecular detection or isolation in in vitro culture) remains rare. In most cases, immuno-competent humans are able to eliminate it naturally. Rare cases of often asymptomatic carriage exist, and only B. divergens, a species of bovine origin, has been detected.
We occasionally collaborate with the hospital environment when analyses for patients suspected of babesiosis are sent to us. We are in the process of characterizing at the molecular level a new species of zoonotic Babesia of group B. divergens6.

1 Jalovecka M, Hajdusek O, Sojka D, Kopacek P, Malandrin L. 2018. The Complexity of Piroplasms Life Cycles. Front Cell Infect Microbiol. 2018 8:248.

2 Lempereur L, Shiels B, Heyman P, Moreau E, Saegerman C, Losson B, Malandrin L. 2015. A retrospective serological survey on human babesiosis in Belgium. Clin Microbiol Infect. 21(1):96.e1-7.

3 Becker CA, Bouju-Albert A, Jouglin M, Chauvin A, Malandrin L. 2009. Natural transmission of zoonotic Babesia spp. by Ixodes ricinus ticks. Emerg Infect Dis. 15(2):320-2.

4 Jouglin M, Perez G, Butet A, Malandrin L, Bastian S. 2017. Low prevalence of zoonotic Babesia in small mammals and Ixodes ricinus in Brittany, France. Vet Parasitol. 2017 Apr 30;238:58-60.

5 Jouglin M., Bastian S., Abou-Bacar A., Ermanno C. De Briel D. Chauvin A. Malandrin L. , 2010. Babésiose humaine clinique et asymptomatique : intérêt et faisabilité d'une veille sanitaire. REID, 18-19 Nov 2010.

6 Martinot et al., 2011. Babesiosis in Immunocompetent Patients, Europe. Emerg. Inf. Dis. 17:114-116.

Contact person :

Publications :

de Carné MC, Moussel F, Laurichesse JJ, Malandrin L, Perronne V. Human Babesiosis: report of a rare case. IDcases soumis.

Paleau A, Candolfi E, Souply L, De Briel D, Delarbre JM, Lipsker D, Jouglin M, Malandrin L, Hansmann Y, Martinot M. 2019. Human babesiosis in Alsace: a retrospective study (2005-2015). Med Mal Infect. Sep 20. pii: S0399-077X(18)30611-5. doi: 10.1016/j.medmal.2019.08.007.


Jouglin M., De La Cotte Nathalie, Bonsergent C., Bastian S., Malandrin L. 2018. La Babésiose humaine : bilan de 10 ans d'analyses. Med Mal Infect. 48:S112-S113. DOI 10.1016/j.medmal.2018.04.284.

Martinot M., Paleau A., Greigert V., Brunet J., Hansmann Y., Jouglin M., Souply L., Jaulhac B., De Briel D., Candolfi E. 2018. Babésiose en France et en Europe : une pathologie à redéfinir. Med Mal Infect. 48:S112. DOI 10.1016/j.medmal.2018.04.284.

International Colloquium

Bonsergent C., de la Cotte N., Jouglin M., de Carné MC., Perronne V., Malandrin L. 2019.
Human babesiosis : molecular characterization of a new etiological agent in the “B. divergens species complex”. International Symposium on Tick-borne pathogens and disease (ITPD), 8-11 Septembre 2019, Vienne, Autriche.

International Colloquium